1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA FRMPD3 CTRPv2 pan-cancer AAC 0.1 0.001
mRNA MTA1 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA GADD45G CTRPv2 pan-cancer AAC 0.11 0.001
mRNA OGFOD2 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA PXDC1 CTRPv2 pan-cancer AAC -0.12 0.001
mRNA TNS3 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA NR2F1 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA GSTA4 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA KRT72 CTRPv2 pan-cancer AAC 0.1 0.001
mRNA RERE CTRPv2 pan-cancer AAC 0.11 0.001
Download CSV